Document is current
Any future updates will be listed below
-
Authors
Hovan, Allan J. https://orcid.org/0000-0003-1639-5281
Brennan, Michael T. https://orcid.org/0000-0003-0638-4335
Hasséus, Bengt https://orcid.org/0000-0003-3088-1550
Raber-Durlacher, Judith E. https://orcid.org/0000-0003-1500-8390
Huysmans, Marie-Charlotte https://orcid.org/0000-0002-3036-7554
Laheij, Alexa M. G. A. https://orcid.org/0000-0003-1291-2798
van Leeuwen, Stephanie J. M. https://orcid.org/0000-0002-4522-3705
Legert, Karin Garming https://orcid.org/0000-0001-8276-0510
Isom, Scott https://orcid.org/0000-0002-6658-3865
Kline, David M. https://orcid.org/0000-0001-6183-3303
Blijlevens, Nicole M. A. https://orcid.org/0000-0002-1801-2072
Johansson, Jan-Erik https://orcid.org/0000-0002-2674-9955
von Bültzingslöwen, Inger https://orcid.org/0000-0001-5509-4954
-
Funding
Funding for this research was provided by:
Wake Forest University
- License Information
-
More Information
Article History
Received: 25 April 2025
Accepted: 21 May 2026
First Online: 3 June 2026
Declarations
:
: This study was performed in accordance with the ethical guidelines of the Declaration of Helsinki. Approval was obtained from the Ethical Review Boards at each study site. Sweden: Regional Ethical Review Board in Gothenburg (513–10, T939-16); Charlotte: Wake Forest School of Medicine Institutional Review Board (IRB00080071); Vancouver: BC Cancer Agency Research Ethics Board (BCCA REB # H11-02350, BCCA REB # H15-02350); Amsterdam and Nijmegen: Medical Ethical Research Committee, Amsterdam university medical center location AMC (NL52117.018.15), registered in the Dutch Trial Register June 17, 2015 (NL 5645). The approval granted in Amsterdam was validated by the IRB of Radboud UMC in Nijmegen.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.
